Category
ANTI-FUNGAL API
ANTI-FUNGAL API
Consistent
Purity
Global-Ready
Molecules
Advanced
Manufacturing
Scalable
Production
Partnership
Support
Fluconazole API has been developed by ASANA Pharmaceutical as part of its antifungal and infectious disease treatment portfolio. Fluconazole API, listed under CAS number 86386-73-4, is a triazole antifungal agent widely used in the treatment of systemic and superficial fungal infections, including candidiasis and cryptococcal meningitis.
ASANA Pharmaceutical specializes in the development and manufacturing of high-purity antifungal APIs such as Fluconazole. With capabilities in triazole synthesis and infection-focused therapeutics, ASANA delivers globally compliant, high-efficacy actives to partners across North America, Europe, and Asia, ensuring reliable supply and consistent pharmaceutical performance.
ASANA Pharmaceutical partners with formulation teams, clinical developers, and infectious disease programs to provide robust antifungal solutions. Fluconazole [CAS No. 86386-73-4] is a broad-spectrum triazole antifungal agent used to treat systemic and mucosal fungal infections, including candidiasis and cryptococcal meningitis. It is a key API in ASANA’s infectious disease and critical care portfolio. As the need for effective antifungal treatments continues to rise, ASANA remains committed to delivering:
Fluconazole API are available on public databases such as Wikipidia!